Immucell (ICCC) news
Recent news
ImmuCell Corp - To discontinue early sales reporting, will report revenue at quarterly events
ImmuCell Corporation (ICCC) has announced that it will discontinue its early sales reporting practice and will instead provide revenue updates during quarterly reporting events. This change reflects a strategic shift in the company’s financial communication approach, aligning with standard…
AInvest Wire · 3d agoImmuCell announces a 46% increase in product sales in quarter three of 2026, based on preliminary, unaudited sales results
ImmuCell Corp. reported a 46% increase in product sales during the third quarter of 2026, based on preliminary, unaudited sales results. The growth reflects strong demand for the company’s offerings and highlights continued momentum in its core markets. The increase follows a period of strategic…
AInvest Wire · 3d agoImmucell Corporation Q2 product sales USD 7.2 million
ImmuCell Corporation (Nasdaq: ICCC) reported preliminary, unaudited product sales of $7.2 million for the second quarter of 2026, according to the company’s historical reporting patterns and sales trends. This figure aligns with the company’s seasonal performance, as demand typically shifts from…
AInvest Wire · Jul 9, 2026Immucell announces a 12% increase in product sales in Q2 of 2026 and a 21% increase in the first six months of 2026, based on preliminary, unaudited sales results
AInvest Wire · Jul 9, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.